EDIT:NASDAQ
Editas Medicine Inc
$2.57
arrow_upward
+0.78%(+0.020) 1D
$2.57
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.55
High
$2.63
Low
$2.48
Mkt. cap
394.70M
Avg. vol.
2.33M
Volume
1.72M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
Open
$2.55
High
$2.63
Low
$2.48
Mkt. cap
394.70M
Avg. vol.
2.33M
Volume
1.72M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
24/7 Wall St.
·
1 hour ago
Bitcoin's Correlation With the S&P 500 Just Hit 0.80. Is Bitcoin Trading Like a Tech Stock Again?
TheStreet
·
44 minutes ago
Why S&P 500 investors may want to look beyond mega-cap tech
Cryptonews.net
·
2 hours ago
XRP Price Prediction: Analyst Warns of $0.80 Crash if S&P 500 Breaks Key Support
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com